PSMA6 is a protein composed of 246 amino acids with a molecular weight of approximately 27 kDa . The theoretical isoelectric point (pI) of this protein is 6.35 . It is expressed in various tissues and is a part of the 20S core proteasome complex, which is involved in the proteolytic degradation of most intracellular proteins .
The primary function of PSMA6 is to participate in the ATP-dependent degradation of ubiquitinated proteins by forming the 26S proteasome when associated with two 19S regulatory particles . This process is essential for maintaining protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions . Additionally, PSMA6 is involved in various cellular processes, including the regulation of the cell cycle, apoptosis, and the immune response .
Mutations or dysregulation of the PSMA6 gene have been associated with several diseases, including myocardial infarction and inflammatory bowel disease . Research has also shown that PSMA6 is critical for the survival of pancreatic ductal carcinoma cell models, indicating its potential role in cancer biology .
Recombinant human PSMA6 is produced using Escherichia coli expression systems and is typically purified to a high degree of purity (>90%) suitable for various applications such as SDS-PAGE and mass spectrometry (MS) . This recombinant protein is valuable for research purposes, including studying the structure and function of the proteasome complex and its role in disease mechanisms.